What do we need to know about drugs that treat COVID and how accessible they are to people who may need them? WebMD Chief Medical Officer drjohnwhyte speaks with Dr. William Schaffner of VUmedicine.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Some firms thrived during Covid and then got their PPP Covid relief loans forgivenIn the early days of the pandemic, the federal government raced to support businesses and consumers undone by Covid shutdowns Now, many PPP borrowers are asking that their loans be forgiven.
Read more »
U.S. looking to broaden access to COVID-19 antiviral pills - WSJThe administration is reviewing whether Paxlovid, the antiviral from Pfizer Inc, can be available on the commercial market in retail pharmacies if it gets regulatory clearance, the Journal reported. Molnupiravir, an oral pill from Merck & Co Inc and Ridgeback Biotherapeutics LP that is also under regulatory review, may be included in the government's plan to make it commercially available, the journal reported, citing the person. The United States has agreed to buy 10 million courses of Pfizer's drug and has so far secured 3.1 million courses of Merck's pill.
Read more »
Covid cases rise yet again in U.S. ahead of Thanksgiving holiday
Read more »
FDA authorizes Pfizer/BioNTech, Moderna COVID-19 boostersThe U.S. Food and Drug Administration on Friday authorized booster doses of COVID-19 vaccines for all adults who were vaccinated with the Pfizer Inc and partner BioNTech SE shot and the Moderna Inc shot.
Read more »
Unvaccinated mom dies of COVID, leaving behind 6 kids; family urges others to get vaccineThe woman's husband said that he regrets that he didn't 'push her' to get the COVID-19 vaccine. She died of complications from the virus on Monday.
Read more »
Wall Street poised for mixed start as investors fret over Europe's COVID casesU.S. stock futures struggled Friday following more record highs for equities, as investors fretted over Europe's rising COVID-19 cases and a lockdown for...
Read more »